A novel mitochondrial amidoxime reducing component 2 is a favorable indicator of cancer and suppresses the progression of hepatocellular carcinoma by regulating the expression of p27

Hepatocellular carcinoma (HCC) is the fifth leading cause of cancer-related mortality in the United States. Exploring the mechanism of HCC and identifying ideal targets is critical. In the present study, we demonstrated metabolism dysfunction might be a key diver for the development of HCC. The mito...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Dehai, Wang, Yan, Yang, Guangchao, Zhang, Shugeng, Liu, Yao, Zhou, Shuo, Guo, Hongrui, Liang, Shuhang, Cui, Yifeng, Zhang, Bo, Ma, Kun, Zhang, Congyi, Liu, Yufeng, Sun, Linmao, Wang, Jiabei, Liu, Lianxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7498369/
https://www.ncbi.nlm.nih.gov/pubmed/32811980
http://dx.doi.org/10.1038/s41388-020-01417-6

Ejemplares similares

Ejemplares similares